Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Ecliptasaponin A (Echinocystic acid-3-o-glucoside) has protective effects against the pulmonary fibrosis induced by bleomycin via reducing the oxidative stress, lung tissue inflammation, and the subsequent epithelial-mesenchymal transition.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
20 mg | In stock | $ 110.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 90.00 |
Description | 1. Ecliptasaponin A (Echinocystic acid-3-o-glucoside) has protective effects against the pulmonary fibrosis induced by bleomycin via reducing the oxidative stress, lung tissue inflammation, and the subsequent epithelial-mesenchymal transition. |
Source |
Synonyms | Echinocystic acid-3-o-glucoside |
Molecular Weight | 634.84 |
Formula | C36H58O9 |
CAS No. | 78285-90-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pyridine, Methanol, etc.: Soluble
Ethanol: Soluble
DMSO: 91 mg/mL(143.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ecliptasaponin A 78285-90-2 Others inhibit Inhibitor Echinocystic acid-3-o-glucoside inhibitor